Literature DB >> 22437201

Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not?

Benzon M Dy1, Melanie L Richards, Bianca J Vazquez, Geoffrey B Thompson, David R Farley, Clive S Grant.   

Abstract

BACKGROUND: The indications for surgery in primary hyperparathyroidism (1HPT) are the same for patients with and without localization on imaging. However, patients with negative imaging may not be referred for surgery or the surgeon may be reluctant to operate. We compare outcomes in patients with negative imaging to those with localization.
METHODS: A review of patients who underwent primary operation for 1HPT with a preoperative Tc99 sestamibi I-123 (MIBI) scan was conducted. Imaging, laboratory, operative findings, pathologic findings, and outcomes were used to compare patients with negative scans to those with localization.
RESULTS: A total of 2,681 patients had an operation for 1HPT with preoperative MIBI. MIBI imaging was negative in 136 (5.7 %). The negative MIBI group had a lower calcium (10.9 vs. 11.0 mg/ml, P=0.02), phosphorus (2.9 vs. 3.1 mg/dl, P<0.001), and urinary calcium (251 vs. 287 mg/ml, P=0.02) and no difference in parathyroid hormone, 25-OH vitamin D, or bone loss. Multigland resection was higher with a negative scan (32 vs. 13 %, P<0.001). A curative operation was performed in 90.4 % with a negative MIBI compared to 97.5 % with localization (P<0.001). Patients who underwent successful surgery despite a negative MIBI scan had lower calcium (10.8 vs. 11.1 mg/ml, P=0.04) and parathyroid hormone (98 vs. 196 pg/ml, P=0.03) than those not cured. Patients with both a negative ultrasound result and negative MIBI had a cure rate of 89 %.
CONCLUSIONS: A curative operation is performed at an acceptably lower rate with negative MIBI imaging. A decision for surgery with a negative MIBI finding should consider lower cure rates and symptom severity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22437201     DOI: 10.1245/s10434-012-2325-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  17 in total

1.  Feasibility of unilateral parathyroidectomy in patients with primary hyperparathyroidism and negative or discordant localization studies.

Authors:  Pietro Giorgio Calò; Fabio Medas; Giulia Loi; Enrico Erdas; Giuseppe Pisano; Angelo Nicolosi
Journal:  Updates Surg       Date:  2016-01-29

2.  A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience.

Authors:  Arif Usta; Etem Alhan; Akif Cinel; Serdar Türkyılmaz; Cihangir Erem
Journal:  Int Surg       Date:  2015-04

Review 3.  [Localization of parathyroid adenomas with C11-methionine PET-CT].

Authors:  T Weber; M Luster
Journal:  Chirurg       Date:  2014-07       Impact factor: 0.955

4.  The small abnormal parathyroid gland is increasingly common and heralds operative complexity.

Authors:  Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

5.  18F-Fluorocholine PET/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism.

Authors:  Alessio Imperiale; David Taïeb; Elif Hindié
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04       Impact factor: 9.236

6.  Diagnostic value of four-dimensional computed tomography and four-dimensional magnetic resonance imaging in primary hyperparathyroidism when first-line imaging was inadequate.

Authors:  N Acar; M Haciyanli; M Coskun; N K Erdogan; S C Celik; S G Haciyanli; E O Gur
Journal:  Ann R Coll Surg Engl       Date:  2020-01-10       Impact factor: 1.891

7.  Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?

Authors:  Theresia Weber; Martin Gottstein; Sabrina Schwenzer; Ambros Beer; Markus Luster
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

8.  Diagnostic value and clinical impact of complementary CT scan prior to surgery for non-localized primary hyperparathyroidism.

Authors:  B Seeliger; P F Alesina; J-A Koch; J Hinrichs; B Meier; M K Walz
Journal:  Langenbecks Arch Surg       Date:  2015-02-22       Impact factor: 3.445

9.  A Multimodal Imaging Protocol, (123)I/(99)Tc-Sestamibi, SPECT, and SPECT/CT, in Primary Hyperparathyroidism Adds Limited Benefit for Preoperative Localization.

Authors:  Grace S Lee; Travis J McKenzie; Brian P Mullan; David R Farley; Geoffrey B Thompson; Melanie L Richards
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

10.  Feasibility of video-assisted bilateral neck exploration for patients with primary hyperparathyroidism and failed or discordant localization studies.

Authors:  Pier Francesco Alesina; Jakob Hinrichs; Matthias Heuer; Sebastian Hofmeister; Beate Meier; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2012-11-25       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.